.Merck beats incomes requirements, rears purchases expectation on strong need for best medicines like Keytruda CNBCMerck & Co. (MRK US) Defeats Earnings Projections as Keytruda Purchases Increase BloombergMerck Sell: Pharma Titan Posts Sturdy End Results, However Expectation Falls Short Real estate investor's Organization DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck defeats profit and purchases requirements surrounded by Keytruda asset, but delivers combined full-year outlook MarketWatch.